Translate
Madrigal Pharmaceuticals, Inc.
About
513.47USD+1.65 +0.32%
Closed • Updated at 13:10 GMT+00:00Market Cap$11.84B
Volume361.1K
Beta0.07
RSI49.17
Gross Margin92.94%
Madrigal Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk
May 6 2026
Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates
May 5 2026
Madrigal Adds Clinical-Stage siRNA Asset Targeting PNPLA3 to its MASH Pipeline
Apr 22 2026
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
Feb 24 2026
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference